|
IT1283876B1
(it)
|
1996-01-12 |
1998-05-07 |
Univ Roma |
Molecole chimeriche ribozima-snrna ad attivita' catalitica per rna a localizzazione nucleare
|
|
US5814500A
(en)
|
1996-10-31 |
1998-09-29 |
The Johns Hopkins University School Of Medicine |
Delivery construct for antisense nucleic acids and methods of use
|
|
US6692910B2
(en)
|
1997-07-28 |
2004-02-17 |
The University Of Connecticut |
Inhibition of a target messenger RNA with a modified U1 small nuclear RNA
|
|
US7056502B2
(en)
|
2000-04-28 |
2006-06-06 |
The Trustees Of The University Of Pennsylvania |
Recombinant aav vectors with AAV5 capsids and AAV5 vectors pseudotyped in heterologous capsids
|
|
WO2002083908A1
(es)
|
2001-03-30 |
2002-10-24 |
Fundacion Para La Investigacion Medica Aplicada |
Procedimiento de inhibicion reversible de la expresion genica mediante ribonucleoproteinas modificadas
|
|
ITRM20020253A1
(it)
|
2002-05-08 |
2003-11-10 |
Univ Roma |
Molecole chimeriche di snrna con sequenze antisenso per le giunzioni di splicing del gene della distrofina e applicazioni terapeutiche.
|
|
FR2874384B1
(fr)
|
2004-08-17 |
2010-07-30 |
Genethon |
Vecteur viral adeno-associe pour realiser du saut d'exons dans un gene codant une proteine a domaines dispensables
|
|
US8822168B2
(en)
|
2005-03-11 |
2014-09-02 |
The Trustees Of The University Of Pennsylvania |
Assays for detecting small nuclear ribonucleoprotein particle assembly and survival of motor neurons activity
|
|
US9040491B2
(en)
|
2006-08-30 |
2015-05-26 |
The Trustees Of The University Of Pennsylvania |
Compositions, methods and kits based on small nuclear RNAs
|
|
US8343941B2
(en)
|
2007-03-30 |
2013-01-01 |
Rutgers, The State University Of New Jersey |
Compositions and methods for gene silencing
|
|
US9441221B2
(en)
|
2007-03-30 |
2016-09-13 |
Rutgers, The State University Of New Jersey |
Compositions and methods for gene silencing
|
|
EP2142672B1
(en)
|
2007-03-30 |
2012-09-05 |
Rutgers, The State University of New Jersey |
Compositions and methods for gene silencing
|
|
US8907075B2
(en)
|
2007-03-30 |
2014-12-09 |
Samuel Ian Gunderson |
Compositions and methods for gene silencing
|
|
ES2714007T3
(es)
|
2007-04-09 |
2019-05-24 |
Univ Florida |
Composiciones de vectores rAAV que tienen proteínas de la cápside modificadas en tirosina y métodos para su uso
|
|
US9080170B2
(en)
|
2010-03-17 |
2015-07-14 |
Association Institut De Myologie |
Modified U7 snRNAs for treatment of neuromuscular diseases
|
|
IT1400425B1
(it)
|
2010-06-08 |
2013-05-31 |
Amsterdam Molecular Therapeutics Bv |
Modified snrnas for use in therapy.
|
|
IT1405793B1
(it)
|
2010-10-15 |
2014-01-24 |
Univ Ferrara |
Molecola di u1snrna umano modificato, gene codificante per la molecola di u1snrna umano modificato, vettore di espressione includente il gene, e loro uso in terapia genica
|
|
US9303258B2
(en)
|
2011-04-05 |
2016-04-05 |
The Regents Of The University Of California |
Method and compositions comprising small RNA agonist and antagonists to modulate inflammation
|
|
MX388221B
(es)
|
2013-04-20 |
2025-03-19 |
Res Institute At Nationwide Children´S Hospital |
ADMINISTRACIÓN DE VIRUS ADENO-ASOCIADO RECOMBINANTE DE CONSTRUCCIONES DE POLINUCLÉOTIDOS U7snRNA DIRIGIDA AL EXÓN 2.
|
|
CA2957661A1
(en)
|
2014-08-09 |
2016-02-18 |
Kevin FLANIGAN |
Methods and materials for activating an internal ribosome entry site in exon 5 of the dmd gene
|
|
US9669109B1
(en)
|
2015-11-24 |
2017-06-06 |
Universita Di Ferrara |
Modified human U1snRNA molecule, a gene encoding for the modified human U1snRNA molecule, an expression vector including the gene, and the use thereof in gene therapy of familial dysautonomia and spinal muscular atrophy
|
|
FR3044926B1
(fr)
|
2015-12-09 |
2020-01-31 |
Genethon |
Outils de therapie genique efficaces pour le saut de l'exon 53 de la dystrophine
|
|
JP6966463B2
(ja)
|
2016-02-26 |
2021-11-17 |
リサーチ インスティチュート アット ネイションワイド チルドレンズ ホスピタル |
組換えウイルス産物及びｄｕｘ４エクソンスキッピングを誘導するための方法
|
|
JP2021534755A
(ja)
|
2018-08-22 |
2021-12-16 |
リサーチ インスティチュート アット ネイションワイド チルドレンズ ホスピタル |
筋強直性ジストロフィープロテインキナーゼの発現を抑制および／またはｄｍｐｋ遺伝子の３’非翻訳領域におけるトリヌクレオチドリピート伸長に干渉するための組換えウイルス産物および方法
|
|
CN113924364A
(zh)
|
2019-03-08 |
2022-01-11 |
罗格斯新泽西州立大学 |
治疗亨廷顿病的组合物和方法
|
|
CA3134683A1
(en)
|
2019-03-26 |
2020-10-01 |
Rutgers, The State University Of New Jersey |
Compositions and methods for treating neurodegenerative disorders
|
|
WO2020214763A1
(en)
*
|
2019-04-18 |
2020-10-22 |
Sarepta Therapeutics, Inc. |
Compositions for treating muscular dystrophy
|
|
US20220348958A1
(en)
|
2019-07-23 |
2022-11-03 |
Oxford Biomedica (Uk) Limited |
Enhancing Production of Lentiviral Vectors
|
|
WO2021026075A1
(en)
|
2019-08-02 |
2021-02-11 |
Research Institute At Nationwide Children's Hospital |
Exon 44-targeted nucleic acids and recombinant adeno-associated virus comprising said nucleic acids for treatment of dystrophin-based myopathies
|
|
US20230059753A1
(en)
|
2019-12-09 |
2023-02-23 |
Astellas Pharma Inc. |
Antisense guide rna with added functional region for editing target rna
|
|
CN115777020A
(zh)
*
|
2020-04-22 |
2023-03-10 |
塑造治疗公司 |
使用snrna组分的组合物和方法
|
|
AU2021349277A1
(en)
|
2020-09-28 |
2023-05-11 |
Research Institute At Nationwide Children's Hospital |
Products and methods for treating muscular dystrophy
|
|
IL303230A
(en)
|
2020-11-30 |
2023-07-01 |
Res Inst Nationwide Childrens Hospital |
Compositions and methods for treating facioscapulohumeral muscular dystrophy (fshd)
|
|
AU2022262420A1
(en)
|
2021-04-23 |
2023-11-16 |
Research Institute At Nationwide Children's Hospital |
Products and methods for treating muscular dystrophy
|
|
AU2023228712A1
(en)
|
2022-03-04 |
2024-10-17 |
Regeneron Pharmaceuticals, Inc. |
Compositions and methods comprising engineered small nuclear rna (snrna)
|